Colistimethate Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 23155-193

9 FDA label images from Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Colistimethate Sodium (NDC 23155-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of colistimethate sodium, showing its peptide chain with multiple L-Dab, L-Thr, D-Leu, and L-Leu residues, and attached sulfonate groups represented by O=S=O and ONa moieties.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A line graph depicting urine and serum colistin base activity levels in mcg/mL over 12 hours in adults after intramuscular (IM) or intravenous (IV) administration of colistimethate for injection. The graph shows separate lines for urine and serum concentrations following IM (dotted lines) and IV (solid lines) routes, with colistin activity decreasing over time in both urine and serum.*
FDA Label Image
FDA Label Image

Vial-emcure (Vial Emcure)

Vial-emcure (Vial Emcure)
Label for Colistimethate Sodium injection, USP, 150 mg per vial, lyophilized powder for solution with colistin base activity for intramuscular and intravenous use. The label includes dosage strength, storage instructions, manufacturer details (Enceure Pharmaceuticals Ltd. and Avet Pharmaceuticals Inc.), vial size, and barcode.*
FDA Label Image

Vial-onesource (Vial Onesource)

Vial-onesource (Vial Onesource)
Label for Colistimethate Sodium for Injection, USP, 150 mg per vial, single dose vial by Avet Pharma. It specifies colistin base activity for intramuscular and intravenous use. Storage instructions include keeping dry powder at 20° to 25°C and reconstituted solution refrigerated or between 20° to 25°C for use within 7 days. Includes barcode and manufacturer details.*
FDA Label Image

Carton-1s-emcure (Carton 1s Emcure)

Carton-1s-emcure (Carton 1s Emcure)
Colistimethate Sodium 150 mg per vial injection powder label for solution by Avet Pharma. The label indicates this is a lyophilized powder for intramuscular and intravenous use, supplied as a single dose vial containing 150 mg colistin base activity. It includes storage instructions and manufacturer information for Emcure Pharmaceuticals Ltd. and Avet Pharmaceuticals Inc.*
FDA Label Image

Carton-1s-onesource (Carton 1s Onesource)

Carton-1s-onesource (Carton 1s Onesource)
Colistimethate injection, USP 150 mg per vial lyophilized powder label for intramuscular and intravenous use. The label shows the product name, strength, usage route, and single-dose vial specification. It is manufactured by OneSource Specialty Pharma Limited for Avet Pharmaceuticals Inc. The label includes storage instructions and prescription-only status.*
FDA Label Image

Carton-12s-emcure (Carton 12s Emcure)

Carton-12s-emcure (Carton 12s Emcure)
Colistimethate injection, USP 150 mg per vial powder for injection, lyophilized, for intramuscular and intravenous use. The label shows packaging for 12 single-dose vials. Manufactured for Avet Pharmaceuticals Inc. by Emcure Pharmaceuticals Ltd., India. Storage and usage instructions are partially visible on the label.*
FDA Label Image

Carton-12s-onesource (Carton 12s Onesource)

Carton-12s-onesource (Carton 12s Onesource)
The packaging label for Colistimethate Sodium injection, USP, powder, lyophilized for solution, 150 mg per vial. The label highlights its use for intramuscular and intravenous administration. The product is supplied in 150 mg x 12 single dose vials and manufactured for Avet Pharmaceuticals Inc. by OneSource Specialty Pharma Limited. The label includes storage instructions for reconstituted solution and dosage guidance, along with the NDC 23155-193-41 and Rx only designation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.